Global Oxidative Stress Assays Market Size, Share & Trends Analysis By Product, By Test Type, By Technology, By Disease Type, By End User, Regional Outlook, Competitive Strategies and Segment Forecasts to 2030

Description

Global oxidative stress assays market is projected to be worth USD 1898 million by 2030.

According to SPER Market Research, the oxidative stress assays market is estimated to reach USD 1898 million by 2030 with a CAGR of 8.6%. Rising prevalence of chronic and lifestyle disorders has led to the growth of biopharmaceutical and biotechnology companies which is further driving the growth of oxidative stress assays market.

Impact of COVID-19 on the Oxidative Stress Assays Market

COVID-19 has a slightly negative impact on oxidative stress assays market due to economic impact on companies, stringent regulatory process, disruptions in supply chain impacting the research activities. In upcoming years, academic research activities will rise leading to growth of oxidative stress assays market.

Scope of the report:

Market size available for years:

Market size available for years: 2019-2030
Base year considered: 2021
Forecast period: 2022-2030

Segments covered

By Product, By Test Type, By Technology, By Disease, By End User

Geographies covered

North America, Europe, APAC, Latin America and the Middle East & Africa

Companies Covered

Abcam, plc, AMS Biotechnology, Arbor Assays, BioVision, Inc., Callegari SRL, Cayman Chemical, Cell Biolabs, Inc., Eagle Biosciences, Inc., Enzo Biochem, Inc., Genox Corporation, Hycult Biotech, ImmunoChemistry Technologies, LLC, Kamiya Biomedical Company, MEGA TIP San.Tic.Ltd.Sti., Merck KGaA, Oxford Biomedical Research, Promega Corporation, QIAGEN N.V., Thermo Fisher Scientific, Inc., Toxys B.V.

Driver: Rapidly growing biotechnology and biopharmaceutical industries

The biopharmaceutical and biotechnological industries are growing with technological advancements and rising demand. Oxidative stress assays are applied in both biopharmaceutical and biotechnological companies in cell cultures. Growth of these industries can drive the growth of oxidative stress assays market in the forecast period.

Restraints: Highly costly instruments

Advanced technologies for oxidative stress assays such as label-free detection and high-content screening are advantageous with advanced features and functions as compared to conventional technologies. Therefore, such instruments are priced at a premium cost. Companies with limited R&D budgets can not afford these instruments. The pharmaceutical companies require large number of such systems, thus overall cost of ownership combined with maintenance and indirect costs becomes very high. Thus, the cost of these instruments can restrain the growth of this market.

Opportunity: Growth opportunities in emerging economies

Emerging economies such as Russia, China, Brazil, India are offering growth opportunities to oxidative stress assays market. Factor attributing these opportunities is increasing R&D funding and investments for research organizations. Asian countries such as India and China have CROs that provide drug discovery services to pharmaceutical industries. The outsourcing of research work helps in increasing the efficiency in limited time.

Oxidative Stress Assays Market by Product:

Based on product, market has been segmented into Consumables, Kits, Reagents, Instruments, Services

Oxidative Stress Assays Market by Test Type:

Based on test type, the market is segmented into Antioxidant Capacity Assays, Ascorbic Acid Assays, Glutathione Assays, Cell-based Exogenous Antioxidant Assays, Indirect Assays, Lipid-based Assays, Nucleic Acid-based Assays, Protein-based Assays, Enzyme-based Assays, Reactive Oxygen Species-based Assays

Oxidative Stress Assays Market by Technology:

Based on technology, market has been segmented into Enzyme-linked Immunosorbent Assay (ELISA), Flow Cytometry, High-content Screening (HCS), Label-free Detection, Microscopy, Chromatography

Oxidative Stress Assays Market by Disease Type:

Based on disease type, market has been segmented into Cardiovascular Disease, Diabetes, Cancer, Respiratory Diseases, Other Diseases

Cardiovascular Disease segment accounted for largest share due to rising prevalence of cardiovascular diseases and unhealthy lifestyle.

Oxidative Stress Assays Market by End User:

Based on end user, the market is segmented into Clinical Laboratories, Contract Research Organizations, Pharmaceutical and Biotechnology Companies, Academic Research Institutes, Cosmetic Companies

Oxidative Stress Assays Market by Region:

North America owns the largest share of this market owing to advanced healthcare infrastructure, rising investments in healthcare, presence of leading players and technological advancement. However, Asia Pacific will grow at the highest CAGR owing to supportive government initiatives, rising awareness, rising investments and rising income.

Product Code: BIOT2212

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1. Research data source
- 2.1.1. Secondary data
- 2.1.2. Primary data
- 2.1.3. SPER's internal database
- 2.1.4. Premium insight from KOL's
2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges
4.2. COVID-19 Impact of the Oxidative Stress Assays Market

5. Market variables and outlook

5.1. SWOT analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
5.2. PESTEL analysis
- 5.2.1. Political landscape
- 5.2.2. Economic landscape
- 5.2.3. Social landscape
- 5.2.4. Technological landscape
- 5.2.5. Environmental landscape
- 5.2.6. Legal landscape
5.3. PORTER'S five forces analysis
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of Buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
5.4. Heat map analysis

6. Global Oxidative Stress Assays Market, By Product, 2019-2030 (USD Million)

6.1. Consumables
6.2. Kits
6.3. Reagents
6.4. Instruments
6.5. Services

7. Global Oxidative Stress Assays Market, By Test Type, 2019-2030 (USD Million)

7.1. Antioxidant Capacity Assays
7.2. Ascorbic Acid Assays
7.3. Glutathione Assays
7.4. Cell-based Exogenous Antioxidant Assays
7.5. Indirect Assays
7.6. Lipid-based Assays
7.7. Nucleic Acid-based Assays
7.8. Protein-based Assays
7.9. Enzyme-based Assays
7.10. Reactive Oxygen Species-based Assays

8. Global Oxidative Stress Assays Market, By Technology, 2019-2030 (USD Million)

8.1. Enzyme-linked Immunosorbent Assay (ELISA)
8.2. Flow Cytometry
8.3. High-content Screening (HCS)
8.4. Label-free Detection
8.5. Microscopy
8.6. Chromatography

9. Global Oxidative Stress Assays Market, By Disease Type, 2019-2030 (USD Million)

9.1. Cardiovascular Disease
9.2. Diabetes
9.3. Cancer
9.4. Respiratory Diseases
9.5. Other Diseases

10. Global Oxidative Stress Assays Market, By End User, 2019-2030 (USD Million)

10.1. Clinical Laboratories
10.2. Contract Research Organizations
10.3. Pharmaceutical and Biotechnology Companies
10.4. Academic Research Institutes
10.5. Cosmetic Companies

11. Global Oxidative Stress Assays Market, By Region, 2019-2030 (USD Million)

11.1. North America
- 11.1.1. United States
- 11.1.2. Canada
- 11.1.3. Mexico
11.2. Europe
- 11.2.1. Germany
- 11.2.2. United Kingdom
- 11.2.3. France
- 11.2.4. Italy
- 11.2.5. Spain
- 11.2.6. Rest of Europe
11.3. Asia-Pacific
- 11.3.1. China
- 11.3.2. Japan
- 11.3.3. India
- 11.3.4. Australia
- 11.3.5. South Korea
- 11.3.6. Rest of Asia-Pacific
11.4. South America
- 11.4.1. Brazil
- 11.4.2. Argentina
- 11.4.3. Rest of South America
11.5. Middle East & Africa
- 11.5.1. Kingdom of Saudi Arabia
- 11.5.2. United Arab Emirates
- 11.5.3. Rest of Middle East & Africa

12. Company Profiles

12.1. Abcam, plc
- 12.1.1. Company details
- 12.1.2. Financial outlook
- 12.1.3. Product summary
- 12.1.4. Recent developments
12.2. AMS Biotechnology
- 12.2.1. Company details
- 12.2.2. Financial outlook
- 12.2.3. Product summary
- 12.2.4. Recent developments
12.3. Arbor Assays
- 12.3.1. Company details
- 12.3.2. Financial outlook
- 12.3.3. Product summary
- 12.3.4. Recent developments
12.4. BioVision, Inc.
- 12.4.1. Company details
- 12.4.2. Financial outlook
- 12.4.3. Product summary
- 12.4.4. Recent developments
12.5. Callegari SRL
- 12.5.1. Company details
- 12.5.2. Financial outlook
- 12.5.3. Product summary
- 12.5.4. Recent developments
12.6. Cayman Chemical
- 12.6.1. Company details
- 12.6.2. Financial outlook
- 12.6.3. Product summary
- 12.6.4. Recent developments
12.7. Cell Biolabs, Inc.
- 12.7.1. Company details
- 12.7.2. Financial outlook
- 12.7.3. Product summary
- 12.7.4. Recent developments
12.8. Eagle Biosciences, Inc.
- 12.8.1. Company details
- 12.8.2. Financial outlook
- 12.8.3. Product summary
- 12.8.4. Recent developments
12.9. Enzo Biochem, Inc.
- 12.9.1. Company details
- 12.9.2. Financial outlook
- 12.9.3. Product summary
- 12.9.4. Recent developments
12.10. Genox Corporation
- 12.10.1. Company details
- 12.10.2. Financial outlook
- 12.10.3. Product summary
- 12.10.4. Recent developments
12.11. Hycult Biotech
- 12.11.1. Company details
- 12.11.2. Financial outlook
- 12.11.3. Product summary
- 12.11.4. Recent developments
12.12. ImmunoChemistry Technologies, LLC
- 12.12.1. Company details
- 12.12.2. Financial outlook
- 12.12.3. Product summary
- 12.12.4. Recent developments
12.13. Kamiya Biomedical Company
- 12.13.1. Company details
- 12.13.2. Financial outlook
- 12.13.3. Product summary
- 12.13.4. Recent developments
12.14. MEGA TIP San.Tic.Ltd.Sti.
- 12.14.1. Company details
- 12.14.2. Financial outlook
- 12.14.3. Product summary
- 12.14.4. Recent developments
12.15. Merck KGaA
- 12.15.1. Company details
- 12.15.2. Financial outlook
- 12.15.3. Product summary
- 12.15.4. Recent developments
12.16. Oxford Biomedical Research
- 12.16.1. Company details
- 12.16.2. Financial outlook
- 12.16.3. Product summary
- 12.16.4. Recent developments
12.17. Promega Corporation
- 12.17.1. Company details
- 12.17.2. Financial outlook
- 12.17.3. Product summary
- 12.17.4. Recent developments
12.18. QIAGEN N.V.
- 12.18.1. Company details
- 12.18.2. Financial outlook
- 12.18.3. Product summary
- 12.18.4. Recent developments
12.19. Thermo Fisher Scientific, Inc.
- 12.19.1. Company details
- 12.19.2. Financial outlook
- 12.19.3. Product summary
- 12.19.4. Recent developments
12.20. Toxys B.V.
- 12.20.1. Company details
- 12.20.2. Financial outlook
- 12.20.3. Product summary
- 12.20.4. Recent developments